D57.412 Sickle-cell thalassemia, unspecified, with splenic sequestration

Name of the Condition

• Sickle-cell thalassemia, unspecified, with splenic sequestration

Summary

Sickle-cell thalassemia, unspecified, with splenic sequestration is a genetic blood disorder resulting from the co-inheritance of sickle cell disease and thalassemia mutations. It causes red blood cells to become abnormal in shape and function, leading to complications such as anemia, pain, and organ damage. The presence of splenic sequestration indicates a severe, acute phase where sickled red blood cells pool in the spleen, potentially causing rapid splenic enlargement and hypovolemia.

Causes

Sickle-cell thalassemia arises from co-inheritance of mutations in the hemoglobin gene (HBB). One parent contributes a sickle cell mutation, while the other contributes a thalassemia mutation. This combination alters hemoglobin structure, resulting in sickle-shaped red blood cells and reduced hemoglobin production. Splenic sequestration occurs when these abnormal cells become trapped in the spleen, leading to pooling and organ enlargement.

Risk Factors

• Family history of sickle-cell disease or thalassemia
• Ethnic backgrounds with higher prevalence of these conditions (e.g., Mediterranean, Middle Eastern, Indian, or African descent)
• Inheriting one sickle cell gene and one thalassemia gene increases the risk of passing the disorder to offspring
• Prior episodes of splenic sequestration or splenic dysfunction

Symptoms

• Sudden, severe abdominal pain due to splenic enlargement
• Rapid drop in hemoglobin levels (acute anemia)
• Weakness, dizziness, or fainting
• Pale skin or mucous membranes
• Rapid heart rate or low blood pressure
• Enlarged spleen (splenomegaly) on physical exam

Diagnosis

Diagnosis involves blood tests to identify sickle-shaped red blood cells, hemoglobin electrophoresis to confirm the thalassemia component, and imaging (e.g., ultrasound) to assess splenic size. Clinical evaluation focuses on signs of acute anemia and splenic enlargement, with urgent labs to measure hemoglobin and reticulocyte counts. Differentiation from other causes of acute anemia or abdominal pain is critical.

Treatment Options

Treatment requires immediate medical intervention to manage acute anemia and prevent hypovolemic shock. Transfusion therapy may be used to restore hemoglobin levels, while hydration and oxygen support address circulatory compromise. In severe cases, splenectomy (surgical removal of the spleen) may be considered if recurrent sequestration occurs, though this carries infection risks. Pain management and monitoring for complications are also essential.

Prognosis and Follow-Up

Prognosis depends on the speed of intervention and underlying disease severity. Acute splenic sequestration can be life-threatening if untreated, but prompt treatment improves outcomes. Long-term follow-up focuses on monitoring for recurrent episodes, managing chronic anemia, and addressing organ damage. Regular blood counts and imaging help track splenic health, especially in patients with prior sequestration.

Complications

• Hypovolemic shock from rapid blood loss into the spleen
• Splenic rupture (rare but serious)
• Increased risk of infections (especially after splenectomy)
• Chronic organ damage from repeated vaso-occlusive events
• Worsening anemia or organ failure if untreated

Lifestyle & Prevention

Preventive measures include avoiding triggers for sickle cell crises (e.g., dehydration, extreme temperatures) and adhering to vaccination schedules to reduce infection risk. Patients should seek prompt care for fever or abdominal pain, as early intervention can prevent severe sequestration. Genetic counseling is recommended for families with a history of these conditions.

When to Seek Professional Help

Seek immediate medical attention for sudden severe abdominal pain, dizziness, or signs of acute anemia (e.g., pale skin, rapid heart rate). These symptoms may indicate splenic sequestration, which requires urgent evaluation to prevent life-threatening complications.

Tips for Medical Coders

Document the presence of splenic sequestration with specificity, including clinical signs (e.g., splenomegaly, acute anemia) and any interventions (e.g., transfusion, imaging). Ensure the code D57.412 is used only when splenic sequestration is the primary manifestation, and differentiate from other crisis types (e.g., vaso-occlusive) based on clinical context.